1Jacoby GA, ArcherGL, N Engl J. Med, 1991,324 -601.
2Payne DJ, Gramp R. Comparative activities of davalanic,Sulbactam and tazobactom against dinically important β-lactanases. Antimcrob Agents Chemother, 1994,38:767.
3Mclaughlin JC, BarryAl, In - vitro activity of five β- lactam/β - lactamase, inhibior combinations against consecutive, isolate of the enterobacter aceae and pseudomonas oceruginosa, J Antimicrob Chemother, 1994,33 : 223 - 230.
5Jaurequi, LE, Appelbaum PC, Fabian TC. Arandomiged dinical study of cefeperazone and sulbactam versus gentamitin and dindamycin in the treatment of intrabdomind infections. J Antrimicrob Chemother, 1990,25 : 423 - 433.
6Sobberingh EE, Maclaren DM, Sehmitz PIM Brief reports:Comparative in- vitro activity of piperacillin - ta20 bactam against recent dinicd is olates,a Dutch national multicentre study. J Antimicrob Chemother, 1994,34 : 777.
7Shinagawa N, YuraJ, Mashita k, etal. Bacteriological and cinical evaluation of tazobactam/piperacillin in infection disease in surgical field. Jap J Antibiot, 1995,48 : 346.
8Shales DM, Bacghman R, Boylen CT, et al, Piperacitlin/tazobactam compared with ticarcillin/davulanate in community acquired bacterial lower respiratory tract infections,J Amimicrob Chcmother, 1994,34:505 - 577.
10Woodnut G, Berry V and MizemL. Simalation of human secrum pharacokinetics of cefa20lin, piperaciuin, and BRL -42715 in rats and efficacty against experimental intraperitoneal infections. Antimidcrob Agcnts Chemother,1992,36. 1427 - 1431.
1van Veen L,Hartman E,Fabri T.In vitro antibiotic sensitivity of strains of Omithobacterium rhinotracheale isolated in The Netherlands betweer 1996 and 1999[J].Vet Rec,2001,149(20):611 -613.
2J.D.Williams.β-Lactamases and β-Lactamase inhibitors[J].international journal of antimicrobial agents,1999,12(suppl 1):S3-S7.
3Karen bush,George A.jacoby,Antone A.Medeiros.A functional classification scheme for b-Lactamases and its correlation with molecular structure[J].antimicrobial agents and chemotheraby,1995,39(6):1211-1233.
4Byawter RJ,Palmer GH,Buswell jF,JStanton A.Clavulanatepotentiated amoxycill in activity in vitro and bioavailability in the dog[J].Vet Rec,1985,116(2):33-36.
5Girard AE,Schelkly WU,Murphy KT,Sawyer PS.Activity of beta -lactamase inhibitor sulbactam plus ampicillin against animal isolates of Pasteurella,Haemophilus,and Staphylococcus[J].Am J Vet Res,1987,48(12):1678-1683.
6Markowska-Daniell,Pejsak Z.Efficacy of a combination of amoxicillin and clavulanic acid in the treatment of pneumonia of pigs[J].Dtsch Tierarztl Wochenschr,1999,106(12):518 -522.
7Senior DF,Gaskin JM,Buergelt CD,Franks PP,Keefe TJ.Amoxycillin and clavulanic acid combination in the treatment of experimentally induced bacterial cystitis in cats[J].Res Vet Sci,1985,39(1):42-46.
8Bywater RJ,Hewett GR,Marshall AB,West B.Efficacy of clavulanate-potentiated amoxycillin in experimental and clinical skin infections[J].Vet Rec,1985,116(7):177-179.
9Grimshaw WT,Colman PJ,Weatherley AJ.The efficacy of sulbactam-ampicillin in the therapy of respiratory disease associated with ampicillin resistant Pasteurella species in housed calves[J].Vet Rec,1987,121(17):393-396.
10Grimshaw WT,Colman PJ,Petrie L.Efficacy of sulbactam ampicillin in the treatment of neonatal calf diarrhoea[J].Vet Rec,1987,121(8):162-166.
